Mukta Arora

17.8k total citations
209 papers, 5.3k citations indexed

About

Mukta Arora is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Mukta Arora has authored 209 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 149 papers in Hematology, 54 papers in Public Health, Environmental and Occupational Health and 45 papers in Oncology. Recurrent topics in Mukta Arora's work include Hematopoietic Stem Cell Transplantation (130 papers), Acute Lymphoblastic Leukemia research (46 papers) and Acute Myeloid Leukemia Research (39 papers). Mukta Arora is often cited by papers focused on Hematopoietic Stem Cell Transplantation (130 papers), Acute Lymphoblastic Leukemia research (46 papers) and Acute Myeloid Leukemia Research (39 papers). Mukta Arora collaborates with scholars based in United States, Canada and Sweden. Mukta Arora's co-authors include Daniel J. Weisdorf, Todd E. DeFor, Mary E.D. Flowers, Margaret L. MacMillan, Bruce R. Blazar, Madan Jagasia, Stephanie J. Lee, Corey Cutler, Claudio G. Brunstein and Linda J. Burns and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Mukta Arora

203 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mukta Arora United States	40	3.8k	1.3k	1.2k	1.1k	1.0k	209	5.3k
Wael Saber United States	31	2.7k 0.7×	822 0.6×	667 0.5×	869 0.8×	612 0.6×	173	3.7k
David Gómez‐Almaguer Mexico	29	1.9k 0.5×	741 0.6×	523 0.4×	579 0.5×	700 0.7×	335	3.0k
Jeffrey L. Winters United States	45	2.2k 0.6×	430 0.3×	1.8k 1.4×	545 0.5×	1.0k 1.0×	172	7.1k
Guillermo J. Ruíz‐Argüelles Mexico	30	2.1k 0.5×	743 0.6×	411 0.3×	521 0.5×	599 0.6×	307	3.2k
Abdulgabar Salama Germany	32	2.4k 0.6×	164 0.1×	1.2k 0.9×	363 0.3×	770 0.7×	141	4.4k
Paolo Rebulla Italy	45	3.2k 0.8×	354 0.3×	314 0.3×	491 0.4×	1.7k 1.6×	208	6.6k
Vijaya Raj Bhatt United States	26	941 0.2×	434 0.3×	384 0.3×	1.4k 1.3×	379 0.4×	245	3.2k
Paul Knöbl Austria	42	3.2k 0.8×	265 0.2×	2.0k 1.6×	359 0.3×	1.2k 1.1×	159	5.6k
Eliana Gotti Italy	31	423 0.1×	282 0.2×	729 0.6×	822 0.7×	503 0.5×	73	3.8k
Smith Giri United States	29	1.2k 0.3×	400 0.3×	188 0.2×	991 0.9×	488 0.5×	262	3.2k

Countries citing papers authored by Mukta Arora

Since Specialization

Citations

This map shows the geographic impact of Mukta Arora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mukta Arora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mukta Arora more than expected).

Fields of papers citing papers by Mukta Arora

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mukta Arora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mukta Arora. The network helps show where Mukta Arora may publish in the future.

Co-authorship network of co-authors of Mukta Arora

This figure shows the co-authorship network connecting the top 25 collaborators of Mukta Arora. A scholar is included among the top collaborators of Mukta Arora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mukta Arora. Mukta Arora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cao, Qing, Fiona He, Angela Krämer, et al.. (2024). The Prevalence of Pretransplant Frailty and Mental Distress in Hematopoietic Cell Transplantation and Association with Clinical Outcomes. Transplantation and Cellular Therapy. 30(9). 919.e1–919.e9. 1 indexed citations

Wang, Shuo, Qing Cao, Matthew J. Yousefzadeh, et al.. (2023). Frailty and pre-frailty associated with physical functional performance and quality of life in breast cancer and bone marrow transplant survivors.. Journal of Clinical Oncology. 41(16_suppl). 12064–12064. 1 indexed citations

Cao, Qing, Mark Juckett, Brian C. Betts, et al.. (2022). Sarcopenia Predicts Inferior Progression Free Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 28(3). S424–S425.

Young, Jo‐Anne H., Najla El Jurdi, Ahmad Rayes, et al.. (2022). Steroid-Sensitive, but Not Steroid-Dependent or Steroid-Resistant Acute Graft-versus-Host Disease, Results in Similar Infection Risk as No Graft-versus-Host Disease following Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 28(8). 509.e1–509.e11. 3 indexed citations

Jurdi, Najla El, Todd E. DeFor, Shernan G. Holtan, et al.. (2022). Predictors and outcomes of flares in chronic graft-versus-host disease. Bone Marrow Transplantation. 57(5). 790–794. 2 indexed citations

Weisdorf, Daniel J., John E. Wagner, Bruce R. Blazar, et al.. (2021). Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant. Bone Marrow Transplantation. 56(6). 1373–1380. 4 indexed citations

Giri, Smith, Yanjun Chen, Jessica Wu, et al.. (2021). Reduction in Late Mortality Among Patients With Multiple Myeloma Treated With Autologous Peripheral Blood Stem Cell Transplantation—A Blood or Marrow Transplant Survivor Study Report. Transplantation and Cellular Therapy. 27(10). 840.e1–840.e7. 3 indexed citations

Holtan, Shernan G., Brian C. Betts, Armin Rashidi, et al.. (2019). Stress responses, M2 macrophages, and a distinct microbial signature in fatal intestinal acute graft-versus-host disease. JCI Insight. 4(17). 20 indexed citations

Warlick, Erica D., Todd E. DeFor, Nelli Bejanyan, et al.. (2018). Reduced-Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long-Term Follow-Up. Biology of Blood and Marrow Transplantation. 25(1). 56–62. 8 indexed citations

10.

Hegerova, Livia, Qing Cao, John Rogosheske, et al.. (2018). Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(12). e20–e25. 11 indexed citations

11.

Chen, Yanjun, Anna Sällfors Holmqvist, Jessica Wu, et al.. (2018). Late Mortality after Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism: A Report from the Blood or Marrow Transplant Survivor Study-2 (BMTSS-2). Biology of Blood and Marrow Transplantation. 25(2). 328–334. 9 indexed citations

12.

Rozmus, Jacob, Amina Kariminia, Barry E. Storer, et al.. (2018). Comprehensive B Cell Phenotyping Profile for Chronic Graft-versus-Host Disease Diagnosis. Biology of Blood and Marrow Transplantation. 25(3). 451–458. 16 indexed citations

13.

Cao, Qing, Nelli Bejanyan, Armin Rashidi, et al.. (2018). Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics. Haematologica. 103(12). 2109–2115. 20 indexed citations

14.

Arora, Mukta, Yanjun Chen, Jessica Wu, et al.. (2017). Long-Term Morbidity Associated with Chronic Graft Vs. Host Disease (cGvHD) - a Blood or Marrow Transplant Survivor Study (BMTSS). Blood. 130. 336–336. 3 indexed citations

15.

Mehta, Rohtesh S., Shernan G. Holtan, Tao Wang, et al.. (2017). Graft-Versus-Host Disease (GVHD)-Free Relapse-Free Survival (GRFS) and Chronic Gvhd (CRFS) in Alternative Donor Hematopoietic Cell Transplantation (HCT) in Pediatric Patients. Blood. 130. 2053–2053. 1 indexed citations

16.

Yu, Jeffrey, Barry E. Storer, Kushi Kushekhar, et al.. (2016). Biomarker Panel for Chronic Graft-Versus-Host Disease. Journal of Clinical Oncology. 34(22). 2583–2590. 89 indexed citations

17.

MacMillan, Margaret L., Marie Robin, Andrew C. Harris, et al.. (2015). A Refined Risk Score for Acute Graft-versus-Host Disease that Predicts Response to Initial Therapy, Survival, and Transplant-Related Mortality. Biology of Blood and Marrow Transplantation. 21(4). 761–767. 161 indexed citations

18.

Üstün, Celalettin, Veronika Bachanová, Ryan Shanley, et al.. (2013). Importance of donor ethnicity/race matching in unrelated adult and cord blood allogeneic hematopoietic cell transplant. Leukemia & lymphoma. 55(2). 358–364. 13 indexed citations

19.

Armenian, Saro H., Can-Lan Sun, Toana Kawashima, et al.. (2011). Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS). Blood. 118(5). 1413–1420. 137 indexed citations

20.

Arora, Mukta. (2008). Therapy of chronic graft-versus-host disease. Best Practice & Research Clinical Haematology. 21(2). 271–279. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact